JAMIE DELP: Open Payments
NPI 1174205678 · GALAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 22 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $456 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $244 |
| Dexcom, Inc. | 2 | $61 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Lilly USA, LLC | 2 | $31 |
| Astellas Pharma US Inc | 1 | $24 |
| Amgen Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: AIRSUPRA, BREZTRI, Dexcom G6 Transmitter, FARXIGA, MOUNJARO, Veozah, REPATHA, REXULTI.
Industry payments across VA — which companies pay providers there.
